The drug colchicine may reduce cardiovascular outcomes among patients with gout, based on a range of retrospective data that suggest improved outcomes and mechanistic connections between gout and ...

In recent years, scientists have increasingly turned their attention to older, affordable drugs to explore whether they offer benefits beyond their original purpose. Colchicine, a cheap and widely ...

Get ready for a deep dive into colchicine and cardiovascular disease! We’ll examine the RCT data, and then pivot to discuss ...

A low dose of a cheap drug commonly used to treat gout could significantly slash the risk of heart attack and stroke in people with existing heart problems, according to new research. Colchicine, a ...

Please provide your email address to receive an email when new articles are posted on . Patients taking colchicine had a weighted hazard ratio of 0.82 (95% CI, 0.69-0.94) for cardiovascular events.

Colchicine use was linked to a 12% reduction in the risk for total joint arthroplasty among patients with gout. Colchicine use is associated with a modest reduction in the long-term risk for total ...

Share on Pinterest Scientists have repurposed a common gout drug to see if it helps reduce heart attacks and strokes in people with cardiovascular disease. Design by MNT; Photography by Eversame, CC ...

Please provide your email address to receive an email when new articles are posted on . More than 25% of patients with gout who use colchicine prophylaxis were on potentially interacting medications.